Laboratory Testing for Clostridium difficile Infections
Clostridium difficile is the most common cause of hospital-associated diarrhea and community-acquired C. difficile infections (CDI) are rapidly increasing. Accurate and rapid diagnosis is important for appropriate treatment and to initiate infection control measures. A number of traditional and molecular testing strategies are available and will be reviewed.
Originally presented December 11, 2012 in Salt Lake City, Utah.
Robert Schlaberg, MD, MPH
Medical Director, Microbial Amplified Detection Laboratory, ARUP Laboratories
Assistant Medical Director, Virology and Molecular Infectious Disease Laboratories
Assistant Professor of Pathology, University of Utah School of Medicine
Dr. Schlaberg is the medical director of the Microbial Amplified Detection Laboratory and an assistant medical director of the Virology and Molecular Infectious Disease laboratories at ARUP, and an instructor of clinical pathology at the University of Utah School of Medicine. He received his MD and doctor medicinæ degrees at the Julius-Maximilians-University in Wuerzburg, Germany and his master of public health at the Mailman School of Public Health at Columbia University in New York City, where he also served as a postdoctoral fellow. Dr. Schlaberg trained in clinical pathology at the Columbia University College of Physicians & Surgeons, where he was the chief clinical pathology resident. He is certified in clinical pathology by the American Board of Pathology and was awarded the Young Investigator Award by the Academy of Clinical Laboratory Physicians and Scientists.
After this presentation, participants will be able to:
- Identify the different testing strategies for Clostridium difficile.
- Compare different testing strategies and list their advantages and disadvantages.
University of Utah School of Medicine and ARUP Laboratories